Loading candles…
Alembic Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs) globally. The company’s business segments include India Branded Business, International Generics, and APIs. It serves markets primarily in India and the United States. Alembic Pharmaceuticals maintains three research and development centers and five manufacturing facilities. The company has a legacy spanning over a century. No information is available regarding its incorporation year, founders, key management, subsidiaries, notable projects, or stock exchange listings.
This page is a live market overview for ALEMBIC PHARMA LTD (APLLTD) on the NSE. As a listed security, ALEMBIC PHARMA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for APLLTD before placing trades on tick2trade.
As of the latest feed, APLLTD last traded at ₹830.1 on NSE, down ₹4.35 (0.52%) from the previous close of ₹834.45. Today's session range is ₹825.5 – ₹851.85, against a 52-week band of ₹635.8 – ₹1,002. Traded volume today stands at 1.56L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for APLLTD in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether APLLTD is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ALEMBIC PHARMA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in APLLTD. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated APLLTD option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026. | 4 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period and financial year ended March 31, 2026 and dividend for the financial year ended March 31, 2026 | 15 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 4 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 5 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 6 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.